Aging Muscle Quietly Loses a Cancer-Fighting Signal. Exercise Can Turn It Back On.
Your muscles may be doing more than keeping you upright: new research suggests they actively send cancer-suppressing signals to other tissues, and that signal fades as muscle weakens with age.
Muscle has long been understood as an endocrine organ, releasing hormones and signaling molecules that influence tissues far from the bicep or quadricep. A study published April 27, 2026 in Nature Communications now adds a striking entry to that list: tiny molecular parcels shed by healthy muscle actively suppress tumor growth, and aging causes muscle to stop producing them. Early-stage research from Duke-NUS Medical School in Singapore suggests, provocatively, that physical activity can switch the process back on.
How Aging Muscle Loses Its Tumor-Suppressing Cargo
The central players are extracellular vesicles, membrane-bound spheres roughly 100 nanometers across that cells use to ferry proteins, lipids, and genetic material to neighbors near and far. Assistant Professor Tang Hong-Wen and the Duke-NUS team sequenced the cargo inside vesicles released by young versus old muscle and found a striking difference: vesicles from young muscle are loaded with miR-7a-5p, a small piece of genetic material with a well-established role in restraining the molecular pathways that drive tumor growth. In aged muscle, miR-7a-5p is scarce.
The decline traces to a single control system. The NOTCH-SDC2 signaling pathway governs how muscle cells build and load their vesicles; as muscle ages, activity in that pathway drops, disrupting both vesicle production and what gets packed inside. The result is fewer protective parcels, carrying less of the molecule that keeps aberrant cell growth in check.
The Cancer-Relevant Stakes for an Aging Population
Sarcopenia, the progressive loss of muscle mass and strength, now recognized as a disease in its own right, affects roughly one in three adults over 60 in Singapore and globally. Clinicians have known for years that low muscle mass correlates with worse outcomes in cancer patients, but the connection has mostly been attributed to frailty, inflammation, and metabolic dysfunction.
This research proposes something more direct. When the team exposed colorectal, lung, and bile duct cancer cells in culture to extracellular vesicles from healthy mouse muscle, the cancer cell numbers dropped sharply. Vesicles from young muscle also reduced age-related stem cell overgrowth in gut tissue of flies and mice, a form of uncontrolled proliferation that can be an early precursor to cancer. The implication is that muscle does not merely correlate with cancer risk; it may actively regulate it, contributing to what researchers describe as a broader picture of how skeletal muscle's secreted molecules influence the tumor microenvironment.
As Tang put it: "As muscles weaken with age, these signals can change in ways that can promote tumor growth."
Fruit Flies, Mice, and Cancer Cells in a Dish: the Experimental Approach
The Duke-NUS team built their evidence across multiple experimental systems. In fruit fly models, they could manipulate muscle aging rapidly and observe downstream effects on gut stem cell behavior. In mice, they isolated extracellular vesicles from muscle tissue at different ages and tracked what happened when those vesicles were introduced to gut tissue or to cultured cancer cells. The in vitro arm tested vesicles against three cancer types, colorectal, lung, and bile duct, giving a cross-tumor signal rather than a single-cancer effect.
To confirm that the NOTCH-SDC2 pathway was the governing mechanism, researchers traced the molecular chain: as pathway activity fell in older muscle, vesicle output dropped and miR-7a-5p content fell with it. Reactivating the pathway restored both. The same reactivation occurred when animals exercised physically, pointing toward a natural intervention that does not require genetic manipulation.
Open Questions Before This Translates to Human Medicine
Every result here comes from animal models or cell culture, and that caveat matters considerably. It is not yet established that the identical NOTCH-SDC2 mechanism operates in aging human muscle, nor that exercise-driven changes in this pathway translate into a meaningful reduction in cancer incidence in people. The researchers themselves acknowledge that human validation studies are the essential next step.
The team plans to examine miR-7a-5p levels in extracellular vesicles from human blood samples, exploring whether the microRNA could serve as a non-invasive biomarker to identify older adults whose muscle-derived tumor suppression has declined. That would be clinically useful even before any therapeutic intervention is proven, given what is already known about exercise safety and benefit for older adults facing cancer.
What Exercise Reactivation Could Mean for Cancer Prevention Research
The finding that physical activity restores NOTCH-SDC2 pathway activity in aging muscle, and with it the production of miR-7a-5p-carrying vesicles, gives researchers a concrete molecular handle on one of exercise's cancer-protective effects. Previous explanations have centered on reduced inflammation, improved insulin sensitivity, and lower circulating growth factors. This pathway adds a distinct mechanism, one that is tissue-specific and directly tied to the vesicle-based communication system that aging disrupts.
If human studies confirm the mechanism, miR-7a-5p levels in blood-borne vesicles could eventually become a tool for stratifying cancer risk in older adults, or even a therapeutic target for people whose sarcopenia is too advanced for exercise alone to reverse. The Duke-NUS group, funded by Singapore's Ministry of Education, the National Research Foundation, and the Diana Koh Innovative Cancer Research Award, frames muscle health not just as a quality-of-life issue but as an active component of the body's cancer defense. That reframing, if it holds in humans, would have implications for how clinicians approach muscle preservation in aging patients well before any cancer diagnosis appears.
Evidence rating
INVESTIGATIONAL — 71/100
Caveats:
- All findings are from fruit fly and mouse models, plus cancer cell cultures — no human data yet.
- The causal link between exercise-restored vesicle output and reduced cancer risk in people has not been established.
- Human validation studies are planned but not yet completed.
Preclinical study using fruit fly and mouse models alongside in vitro cancer cell assays. Establishes a mechanistic chain but cannot demonstrate causation in humans; all findings require validation in human tissue before clinical implications can be drawn. Not yet replicated in an independent laboratory.
References
- Kah Yong Goh, Wen Xing Lee, Qian Gou, et al. (2026). Sarcopenia promotes tumorigenesis by disrupting NOTCH-SDC2-regulated biogenesis of muscle-derived extracellular vesicles. Nature Communications. https://doi.org/10.1038/s41467-026-72410-y
- Darya Kupriyanova, Airat Bilyalov, Nikita Filatov, et al. (2025). Neural Cues and Genomic Clues: NGS Insights into Neurogenic Sarcopenia and Muscle Atrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211185
- Se-Young Park, Byeong-Oh Hwang, Na-Young Song (2023). The role of myokines in cancer: crosstalk between skeletal muscle and tumor. BMB Reports. https://doi.org/10.5483/bmbrep.2023-0064
- Peggy S. Burhenn, Ashley Leak Bryant, Karen M. Mustian (2016). Exercise Promotion in Geriatric Oncology. Current Oncology Reports. https://doi.org/10.1007/s11912-016-0538-5
